Previous studies have shown that C1q is the first recognition subcomponent of the complement classical pathway, which is comprised of three chains: C1qA, C1qB, and C1qC, and plays complex effects in the occurrence of various tumors, such as prostate cancer 41, ovarian cancer 42 and gliomas 43. This evidence concerns the gene C1QB and ovarian cancer.